# Octapharma Plasma, Inc. – FDA Inspection, Oct 25, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/cbd3c99c-f875-4176-b149-cb518d9f1648
Source feed: FDA_Inspections

> FDA inspection 1221817 of Octapharma Plasma, Inc., October 25, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221817
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2023-10-25
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/melsomar-r-ramos/395e7ddc-ed98-455a-a143-0ee5f46804f4)
- [Investigator](https://www.keypedia.com/people/paul-m-chefor/96bea4a8-b1ee-4870-ae8b-24794c67da21)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/de2f82d1-0586-4da2-86d5-605230a7c34f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d